These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6720383)

  • 1. Hypouricemia and medullary carcinoma of the thyroid.
    Puig JG; Mateos AF; Gaspar G; Martinez EM; Ramos T; Lesmes A
    Adv Exp Med Biol; 1984; 165 Pt A():211-3. PubMed ID: 6720383
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypouricemia and medullary carcinoma of the thyroid gland].
    Gaspar G; Martínez ME; Lisbona A; Lázaro P; Mateos F; Alberó R; García Puig J; Vázquez JJ
    Med Clin (Barc); 1982 Dec 1-31; 79(10):464-7. PubMed ID: 7154724
    [No Abstract]   [Full Text] [Related]  

  • 3. [Calcitonin and its significance for the diagnosis of medullary carcinoma of the thyroid].
    Gautvik KM
    Tidsskr Nor Laegeforen; 1973 May; 93(15):1143-8. PubMed ID: 4584540
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma calcitonin in medullary thyroid carcinoma.
    Lancet; 1983 Feb; 1(8320):338-9. PubMed ID: 6130340
    [No Abstract]   [Full Text] [Related]  

  • 5. [Endocrinological and clinicopathological studies on medullary thyroid carcinoma. Part 1: Preoperative diagnosis of medullary thyroid carcinoma--physical and roentgenologic findings and determination of plasma calcitonin level (author's transl)].
    Obara T
    Nihon Gan Chiryo Gakkai Shi; 1976 Dec; 11(4):745-57. PubMed ID: 1035237
    [No Abstract]   [Full Text] [Related]  

  • 6. [Calcitonin as a tumor marker. I. Medullary carcinoma of the thyroid].
    Galán Galán F; Garrido Peralta M
    Rev Clin Esp; 1982 Apr; 165(1):5-9. PubMed ID: 7122936
    [No Abstract]   [Full Text] [Related]  

  • 7. Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma.
    Diez JJ; Iglesias P
    Thyroid; 2004 Nov; 14(11):984-5. PubMed ID: 15678599
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlation between calcitonin and carcinoembryonic antigen levels in medullary carcinoma of the thyroid.
    Calmettes C; Moudktar MS; Milhaud G
    Biomedicine; 1977 Mar; 27(2):52-4. PubMed ID: 861349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Calcitonin release provoked by intravenous pentagastrin in medullary carcinoma of thyroid.
    Moers AM; Mulder H; Su CA; Visser JL; van de Wiel TW
    Lancet; 1975 May; 1(7914):1035. PubMed ID: 48705
    [No Abstract]   [Full Text] [Related]  

  • 10. [Calcitonin determination as a possibility for the evaluation of surgical result in medullary thyroid carcinoma (C-cell carcinoma)].
    Horn J; Pfarr B; Ziegler R
    Langenbecks Arch Chir; 1975; Suppl():231-4. PubMed ID: 1207235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcohol-stimulated calcitonin release in medullary carcinoma of the thyroid.
    Cohen SL; MacIntyre I; Grahame-Smith D; Walker JG
    Lancet; 1973 Nov; 2(7839):1172-3. PubMed ID: 4127549
    [No Abstract]   [Full Text] [Related]  

  • 12. Spuriously elevated plasma calcitonin in a patient with a thyroid nodule not associated with medullary thyroid carcinoma.
    Lamb EJ; Heddle RM; Ellis A
    Postgrad Med J; 1999 May; 75(883):289-90. PubMed ID: 10533634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a somatostatin analog (SMS 201-995) in perfusion on basal and pentagastrin-stimulated calcitonin levels in medullary thyroid carcinoma.
    Modigliani E; Chayvialle JA; Cohen R; Perret G; Guliana JM; Vassy R; Roger P; Siame-Mourot C; Bennet M; Bentata-Pessayre M
    Horm Metab Res; 1988 Dec; 20(12):773-5. PubMed ID: 2906036
    [No Abstract]   [Full Text] [Related]  

  • 14. [Value of calcitonin determination in the evaluation of completeness of thyroidectomy in medullary carcinoma of the thyroid gland].
    Wasylewski A; Skrzypek J; Kokot F; Sledziński Z
    Endokrynol Pol; 1981; 32(3):239-44. PubMed ID: 7308165
    [No Abstract]   [Full Text] [Related]  

  • 15. Calcitonin in plasma and cerebrospinal fluid from normal subjects and patients with medullary thyroid carcinoma: possible restriction of calcitonin by the blood-brain barrier.
    Morimoto S; Nishimura J; Miyauchi A; Takai S; Okada Y; Onishi T; Fukuo K; Lee S; Kumahara Y
    J Clin Endocrinol Metab; 1982 Sep; 55(3):594-6. PubMed ID: 7096542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining provocative agents of calcitonin to detect medullary carcinoma of the thyroid.
    Sisson JC; Gross MD; Frietas JE; Jackson CE; England BG
    Henry Ford Hosp Med J; 1981; 29(2):75-80. PubMed ID: 7263287
    [No Abstract]   [Full Text] [Related]  

  • 17. High serum levels of calcitonin are not pathognomonic of medullary thyroid carcinoma and may indicate polyglandular autoimmune syndrome III.
    Mazokopakis EE; Karefilakis CM; Batistakis AG; Syros PK; Kalathas TG; Starakis IK
    Hell J Nucl Med; 2010; 13(1):67-8. PubMed ID: 20411177
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunoreactive calcitonin in medullary carcinoma of the thyroid and in maternal and cord serum.
    Samaan NA; Hill CS; Beceiro JR; Schultz PN
    J Lab Clin Med; 1973 May; 81(5):671-81. PubMed ID: 4735426
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic dependability of calcitonin assay in family studies for medullary thyroid carcinoma.
    Jackson CE; Tashjian AH; Block MA
    J Lab Clin Med; 1971 Nov; 78(5):817-8. PubMed ID: 5128860
    [No Abstract]   [Full Text] [Related]  

  • 20. Calcitonin secretion in medullary carcinoma of the thyroid.
    Frölich M; Heersche JN; Lemkes HH; Thesingh CW
    Horm Metab Res; 1972 Sep; 4(5):407. PubMed ID: 4345756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.